CYTK
Cytokinetics
$73.62
−$0.49 (−0.66%)Sep 10, 2026
Key metrics
The numbers that frame CYTK today
- Market cap
- $10.23B
- P/E (TTM)
- -11.4
- EV / FCF
- -19.4
- Gross margin
- 88%
- EV / Sales
- 166.3
- ROIC
- -34.8%
- Div yield
- 0%
- 52wk Low
- $47.22
- 52wk High
- $88.31
Growth
Revenue and earnings trend for CYTK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CYTK
Is Cytokinetics a good buy?
Hold. Cytokinetics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Cytokinetics is selling at a very high price.
What is the market capitalization of CYTK?
Cytokinetics's market capitalization is $10.23B.
What is the P/E ratio for CYTK stock?
Cytokinetics's current P/E ratio is -11.4.
What is the 52-week high for CYTK stock?
The 52-week high for Cytokinetics is $88.31. The current close of $73.62 is 16.6% below that high.
What is the 52-week low for CYTK stock?
The 52-week low for Cytokinetics is $47.22. The current close of $73.62 is 55.9% above that low.
Does CYTK stock pay dividends?
Cytokinetics does not currently show a dividend per share in the company data.